Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role.
Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock and on LinkedIn.
Summary of Position:
The Associate Director, Clinical Sciences is a key position in our Clinical Development Group that will help drive the next phase of Scholar Rock’s growth with energy and dedication. This candidate will drive strategy and decision-making in collaboration with other functions by ensuring relevant information, analysis, and expertise are considered. This position requires a highly organized, collaborative, and adept clinical scientist with strong critical thinking skills, attention to detail, and agility. The current position is focused on the investigational agent apitegromab and its development for Spinal Muscular Atrophy (SMA) as well as other neuromuscular indications, including supportive activities and study oversight. Responsibilities may encompass clinical programs in phases 1 through 4.
Scholar Rock is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
If an employer mentions a salary or salary range on their job, we display it as an "Employer Estimate". If a job has no salary data, Rise displays an estimate if available.
As the Associate Director of Clinical Sciences at Scholar Rock, you will be a driving force in our mission to develop transformative therapies for serious diseases. Working remotely, your role is integral to our Clinical Development Group, where your expertise will contribute to the advancement of innovative treatments, with a specific focus on apitegromab for Spinal Muscular Atrophy (SMA) and additional neuromuscular conditions. At Scholar Rock, we are proud to lead the way in utilizing the biology of the transforming growth factor beta (TGFβ) superfamily, with a commitment to addressing high unmet medical needs through cutting-edge science. Your responsibilities will involve collaborating with cross-functional teams, synthesizing critical data, and designing robust clinical studies. With your strong critical thinking skills and attention to detail, you'll anticipate challenges and identify opportunities ahead of time, helping shape our clinical strategies. The ideal candidate will have a deep understanding of clinical study design and the ability to foster relationships with external advisors, making a real impact in the biotech field. If you're passionate about improving patient outcomes and want to help us unlock new possibilities in treatment options, Scholar Rock eagerly awaits your input and leadership.
Relentlessly focused on seeing new possibilities in deep structural insights, validated biologies and antibody technologies to allow us to move with speed and urgency to deliver high-impact medicines to patients with devastating diseases.
18 jobsSubscribe to Rise newsletter